This Article  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

WILLARD E. FEE, JR, MD
Stanford, Calif

Arch Otolaryngol Head Neck Surg. 1989;115(2):139.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

At the Triological Society section meeting of the combined otolaryngology spring meeting in Palm Beach, Fla, Dr Schuller and colleagues reported on the final report of a prospective, randomized study comparing standard therapy (surgery plus postoperative radiation) with induction chemotherapy, which included the administration of cisplatin, 50 mg/m² intravenously (IV) on day 1; methotrexate, 40 mg/m² IV on day 1; bleomycin, 15 U/m² IV on days 1 and 8; and vincristine sulfate, 2 mg IV on day 1 for three courses, with 21 days between courses, and an additional 21 days after chemotherapy rest, prior to surgery. Of the 175 patients entered into the study, 158 were eligible for the study, and of these, 76 were randomized to receive standard treatment and 82 were randomized to receive chemotherapy. All patients had operable stage III or stage IV epidermoid carcinoma of the head and neck. The overall chemotherapy . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?